Zimmer Biomet Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
5.9%projected annual EPS growth
Analyst Coverage
21analysts covering
FY Revenue (est.)
$8.6Bnext fiscal year
FY EPS (est.)
$8.53next fiscal year
Monitoring Framework
Key Performance Indicators
Organic Constant Currency Revenue Growth Quarterly290.0%Target: 1.0% - 3.0%
Adjusted Diluted EPS Quarterly2.1Target: $8.40 - $8.55
Reported Revenue Growth Quarterly930.0%Target: 2.5% - 4.5%
Watch Items
- Integration of Paragon 28 Acquisition
Research as of 2 Sep 2026